Glaxosmithkline Pharmaceuticals Q1 Results
- BSE: 500660
- NSE: GLAXO
- ISIN: INE159A01016
- Sector: Biotechnology & Drugs
BSE
2,345.9
-69.30 (-2.87%)
-69.30 (-2.87%)Volume4.41 K
Updated: Mon 25 Nov, 2024 | 15:40:02
NSE
2,341.65-70.15 (-2.91%)
-70.15 (-2.91%)Volume1.12 L
Updated: Mon 25 Nov, 2024 | 15:43:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Glaxosmithkline Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 23 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 814.65 | 787.45 | -% | 761.66 | -% |
| Selling/ General/ Admin Expenses Total | 151.28 | 148.84 | -% | 165.00 | -% |
| Depreciation/ Amortization | 16.41 | 17.18 | -% | 16.36 | -% |
| Other Operating Expenses Total | 137.56 | 124.08 | -% | 156.66 | -% |
| Total Operating Expense | 600.52 | 624.49 | -% | 616.84 | -% |
| Operating Income | 214.13 | 162.96 | -% | 144.82 | -% |
| Net Income Before Taxes | 249.40 | 189.97 | -% | 180.98 | -% |
| Net Income | 182.33 | 133.43 | -% | 132.25 | -% |
| Diluted Normalized EPS | 10.76 | 7.45 | -% | 7.06 | -% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST